Anti-NMDA receptor encephalitis causes

Anti-NMDA receptor encephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anti-NMDA receptor encephalitis from Other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anti-NMDA receptor encephalitis causes On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis causes All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anti-NMDA receptor encephalitis causes
CDC on Anti-NMDA receptor encephalitis causes
Anti-NMDA receptor encephalitis causes in the news
Blogs on Anti-NMDA receptor encephalitis causes
Directions to Hospitals Treating Anti-NMDA receptor encephalitis
Risk calculators and risk factors for Anti-NMDA receptor encephalitis causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; AE Dheeraj Makkar, M.D.[2]

Causes

Antibodies and the tumors producing them

Antibodies	Antigens	Associated symptoms	Tumors
Anti-Hu (ANNA-1)	HuD	Encephalomyelitis, limbic encephalitis, cerebellar degeneration, brain stem encephalitis, multi-segmental myelitis, sensory neuronopathy, sensory motor neuropathy, autonomic neuropathy	Lung cancer (85%), mostly SCLC, neuroblastoma, prostate carcinoma
Anti-Yo (PCA-1)	CDR2, CDR62	Paraneoplastic cerebellar degeneration	Ovarian, breast cancer
Anti-CV2(CRMP5)	CRMP5	Encephalomyelitis, polyneuropathy, optic neuritis, limbic encephalitis, choreatic syndromes, cerebellar degeneration	SCLC, thymoma
Anti-Ta/Ma2	MA-proteins	Limbic encephalitis, rhombencephalitis, male>>female	Testicular cancer
Anti-Ri (ANNA-2)	NOVA-1	Opsoclonus–myoclonus syndrome, rhombencephalitis, cerebellar degeneration, myelitis, jaw dystonia, laryngospasm	Breast, ovarian carcinoma, SCLC
Anti-amphiphysin	Amphiphysin	Stiff-person syndrome, limbic encephalitis, rhombencephalitis, cerebellar degeneration, polyneuropathy	Breast cancer, SCLC
Anti-recoverin	Recoverin	Retinopathy	SCLC
Anti-SOX-1 (AGNA)	SOX-1	Non-syndrome-specific	Sensitivity 67%, specificity 95% for SCLC in LEMS

Partially characterized onconeural antibodies (antigen not characterized or positive predictive value for tumor unknown)

Antibodies	Antigens	Associated symptoms	Tumors
Anti-Tr (PCA-Tr)	DNER	Cerebellar degeneration	Hodgkin lymphoma, non-Hodgkin lymphoma
Anti-Zic4	ZIC1-4	Cerebellar degeneration	SCLC
PCA-2	280 kD	Encephalitis, Lambert–Eaton myasthenic syndrome, polyneuropathy	SCLC
ANNA-3	170 kD	Neuropathy, cerebellar degeneration, limbic encephalitis	SCLC

SCLC: Small cell lung carcinoma; LEMS: Lambert–Eaton myasthenic syndrome (LEMS) DNER: delta/notch-like epidermal growth factor-related receptor